TTM
$25.45B
YoY change
+15.4%
5Y CAGR
+7.2%
Peak year (2025)
$24.61B
Cumulative gross profit
$466.32B
Gross Profit history chart for Abbott Laboratories (ABT) from 1985 to 2025
Latest: $24.61B
Gross Profit growth chart for Abbott Laboratories (ABT) from 1985 to 2025
Latest: +15.4%
Gross Profit history table for Abbott Laboratories (ABT) from 1985 to 2025
| 2025 | $24.61B | +15.4% | +$3.28B | ||
| 2024 | $21.32B | +6.4% | +$1.29B | ||
| 2023 | $20.04B | -10.2% | −$2.29B | ||
| 2022 | $22.32B | -3.8% | −$891.00M | ||
| 2021 | $23.21B | +33.6% | +$5.84B | ||
| 2020 | $17.38B | +4.1% | +$684.00M | ||
| 2019 | $16.69B | +5.5% | +$870.00M | ||
| 2018 | $15.82B | +21.1% | +$2.76B | ||
| 2017 | $13.07B | +16.2% | +$1.82B | ||
| 2016 | $11.24B | +2.6% | +$284.00M | ||
| 2015 | $10.96B | +4.5% | +$470.00M | ||
| 2014 | $10.49B | +6.4% | +$633.00M | ||
| 2013 | $9.86B | -9.2% | −$997.00M | ||
| 2012 | $10.85B | -53.7% | −$12.59B | ||
| 2011 | $23.44B | +13.8% | +$2.85B | ||
| 2010 | $20.59B | +16.9% | +$2.97B | ||
| 2009 | $17.62B | +3.4% | +$574.85M | ||
| 2008 | $17.04B | +16.9% | +$2.46B | ||
| 2007 | $14.59B | +13.6% | +$1.74B | ||
| 2006 | $12.84B | +8.2% | +$971.48M | ||
| 2005 | $11.87B | +10.0% | +$1.07B | ||
| 2004 | $10.80B | +5.8% | +$588.71M | ||
| 2003 | $10.21B | +11.2% | +$1.03B | ||
| 2002 | $9.18B | +7.5% | +$641.54M | ||
| 2001 | $8.54B | +13.7% | +$1.03B | ||
| 2000 | $7.51B | +4.3% | +$306.83M | ||
| 1999 | $7.20B | +1.7% | +$117.04M | ||
| 1998 | $7.08B | +3.6% | +$245.62M | ||
| 1997 | $6.84B | +8.9% | +$556.32M | ||
| 1996 | $6.28B | +10.5% | +$595.07M | ||
| 1995 | $5.69B | +10.2% | +$524.21M | ||
| 1994 | $5.16B | +9.3% | +$439.06M | ||
| 1993 | $4.72B | -1.1% | −$51.28M | ||
| 1992 | $4.77B | +16.0% | +$658.80M | ||
| 1991 | $4.12B | +14.2% | +$511.10M | ||
| 1990 | $3.60B | +15.1% | +$474.00M | ||
| 1989 | $3.13B | +9.7% | +$275.80M | ||
| 1988 | $2.85B | +12.8% | +$325.00M | ||
| 1987 | $2.53B | +18.3% | +$391.00M | ||
| 1986 | $2.14B | +17.4% | +$317.60M | ||
| 1985 | $1.82B | — | — |
- 2025$24.61B+15.4%
- 2024$21.32B+6.4%
- 2023$20.04B-10.2%
- 2022$22.32B-3.8%
- 2021$23.21B+33.6%
- 2020$17.38B+4.1%
- 2019$16.69B+5.5%
- 2018$15.82B+21.1%
- 2017$13.07B+16.2%
- 2016$11.24B+2.6%
- 2015$10.96B+4.5%
- 2014$10.49B+6.4%
- 2013$9.86B-9.2%
- 2012$10.85B-53.7%
- 2011$23.44B+13.8%
- 2010$20.59B+16.9%
- 2009$17.62B+3.4%
- 2008$17.04B+16.9%
- 2007$14.59B+13.6%
- 2006$12.84B+8.2%
- 2005$11.87B+10.0%
- 2004$10.80B+5.8%
- 2003$10.21B+11.2%
- 2002$9.18B+7.5%
- 2001$8.54B+13.7%
- 2000$7.51B+4.3%
- 1999$7.20B+1.7%
- 1998$7.08B+3.6%
- 1997$6.84B+8.9%
- 1996$6.28B+10.5%
- 1995$5.69B+10.2%
- 1994$5.16B+9.3%
- 1993$4.72B-1.1%
- 1992$4.77B+16.0%
- 1991$4.12B+14.2%
- 1990$3.60B+15.1%
- 1989$3.13B+9.7%
- 1988$2.85B+12.8%
- 1987$2.53B+18.3%
- 1986$2.14B+17.4%
- 1985$1.82B—
Gross Profit values are taken from Abbott Laboratories's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's current gross profit (TTM) is $25.45B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual gross profit for Abbott Laboratories (ABT) came in at $24.61B – grew 15.4% year-over-year.
Through 2020–2025 (5 years), Abbott Laboratories gross profit delivered a +7.2% annualised rate; sustaining 2 straight years of year-over-year growth.
The highest annual gross profit of $24.61B was reported in 2025. The lowest in the available history was $1.82B in 1985.
Abbott Laboratories Gross Profit by Year
Abbott Laboratories Gross Profit 2025: $24.61B
In 2025, Abbott Laboratories reported gross profit of $24.61B, grew 15.4% from 2024. This figure represents the highest annual value in the available history.
Abbott Laboratories Gross Profit 2024: $21.32B
Abbott Laboratories gross profit in 2024 was $21.32B, grew 6.4% from 2023.
Abbott Laboratories Gross Profit 2023: $20.04B
2023's gross profit for Abbott Laboratories came in at $20.04B, declined 10.2% below 2022.
Abbott Laboratories Gross Profit 2022: $22.32B
Abbott Laboratories posted gross profit of $22.32B in 2022, edged down 3.8% below 2021.
Abbott Laboratories Gross Profit 2021: $23.21B
Abbott Laboratories gross profit in 2021 was $23.21B.
See more financial history for Abbott Laboratories (ABT).
Sector peers by Gross Profit
Healthcare peers of Abbott Laboratories (ABT), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation